After-Hours Stock Movers 12/07: (SFIX) (HOLI) (SMAR) Higher; (MRNS) (IBIO) (ARCT) Lower (more...)

Go back to After-Hours Stock Movers 12/07: (SFIX) (HOLI) (SMAR) Higher; (MRNS) (IBIO) (ARCT) Lower (more...)

GrowGeneration Corp. (GRWG) Prices 5M Share Upsized Common Offering at $30/Sh

December 9, 2020 7:04 AM EST

GrowGeneration Corp. (NASDAQ: GRWG) today announced the pricing of an underwritten public offering of 5,000,000 shares of its common stock at an offering price of $30.00 per share (the "Offering"). GrowGen expects the gross proceeds from the Offering to be approximately $150 million, before deducting the underwriting... More

ATARA Biotherapeutics (ATRA) Prices 5.102M Share Common Offering at $24.50/Sh

December 9, 2020 6:11 AM EST

Atara Biotherapeutics, Inc. (NASDAQ: ATRA), a pioneer in T-cell immunotherapy leveraging its novel allogeneic EBV T- cell platform to develop transformative therapies for patients with serious diseases including solid tumors, hematologic cancers and autoimmune diseases, today announced the pricing of an underwritten public offering of 5,102,041 shares of its common stock at a price to the public of $24.50 per share and, to... More

Sutro Biopharma Inc. (STRO) Prices 6M Share Common Offering at $21/Sh

December 9, 2020 6:10 AM EST

Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company focused on the application of precise protein engineering and rational design to create next-generation cancer and autoimmune therapeutics, today announced the pricing of an underwritten public offering of 6,000,000 shares of its common stock at a price to the public of $21.00 per share. The gross proceeds... More

Marinus Pharma (MRNS) Prices 5M Share Common Offering for Gross Proceeds of $70M

December 8, 2020 9:44 AM EST

Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat rare seizure disorders, today announced the pricing of an underwritten public offering of 5 million shares of its common stock for gross proceeds of $70 million, before deducting the underwriting discounts and commissions and other estimated offering expenses... More

Coupa Software (COUP) PT Raised to $320 at Mizuho Securities

December 8, 2020 7:11 AM EST

Mizuho Securities analyst Siti Panigrahi raised the price target on Coupa Software (NASDAQ: COUP) to $320.00 (from $270.00) while maintaining a Buy rating.

The analyst commented, "Coupa reported a strong FQ3, exceeding consensus expectations across the board. Billings beat by ~$26M as the company... More

Coupa Software (COUP) PT Raised to $385 at Needham & Company

December 8, 2020 6:31 AM EST

Needham & Company analyst Ryan MacDonald raised the price target on Coupa Software (NASDAQ: COUP) to $385.00 (from $300.00) while maintaining a Buy rating.

The analyst commented, "We reiterate our Buy rating and raise our PT to $385 after Coupa reported impressive 3Q results that saw... More

Stitch Fix, Inc. (SFIX) PT Raised to $55 at Needham & Company

December 8, 2020 6:24 AM EST

Needham & Company analyst Rick Patel raised the price target on Stitch Fix, Inc. (NASDAQ: SFIX) to $55.00 (from $46.00) while maintaining a Buy rating.

The analyst commented, "While SFIX reported better than expected F1Q21 results, the bigger news is that active... More

Arcturus Therapeutics (ARCT) Prices 1.365M Share Common Offering at $110/Sh

December 8, 2020 6:05 AM EST

Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT), a leading clinical-stage messenger RNA medicines company focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases, today announced the pricing of an underwritten public offering of 1,365,000 shares of... More